3 Patents
- US125901332026IL-13/IL-4 Superkines: Immune Cell Targeting Constructs and Methods of Use Thereof
Medicenna Therapeutics Inc.
0 cites - US124199542025Targeted Chimeric Antigen Receptor Modified T Cells for Treatment of Il13rα2 Positive Malignancies
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US119936392024Therapeutic IL-13 Polypeptides
The Board Of Trustees Of The Leland Stanford Junior University
0 cites